Digest Network Come funziona
Network
/
Società
Zo
Non verificato

Zoetis Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteVeterinariaVetrine/Shopping

75 comunicati stampa

Guarda tutti i comunicati
20/10/2026
Biotecnologia
Igiene alimentare
Salute
Veterinaria
Farmaceutica
Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
13/10/2026
Scienza
Veterinaria
Biotecnologia
Farmaceutica
Salute
Associazioni/Professionisti
Mercato del lavoro
Zoetis Appoints Iris Knobloch to its Board of Directors
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
08/10/2026
Titoli e azioni
Scienza
Veterinaria
Biotecnologia
Farmaceutica
Salute
Sanità
Zoetis Declares Fourth Quarter 2026 Dividend
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
06/10/2026
Industria
Veterinaria
Scienza
HIV, AIDS e malattie autoimmuni
Animali
Medicina - Varie
Biotecnologia
Farmaceutica
Vetrine/Shopping
Salute
New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
02/09/2026
Eventi
Web e Social Network
Scienza
Veterinaria
Biotecnologia
Farmaceutica
Animali
Salute
Vetrine/Shopping
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
13/08/2026
Industria
Veterinaria
HIV, AIDS e malattie autoimmuni
Igiene alimentare
Animali
Biotecnologia
Farmaceutica
Vetrine/Shopping
Salute
Agricoltura
Materie prime
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
06/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Veterinaria
Animali
Vetrine/Shopping
Zoetis Announces Second Quarter 2026 Results
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
06/08/2026
Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
22/07/2026
Biotecnologia
Pubblico Esercizio/Vendita al dettaglio
Sanità
Salute
Farmaceutica
Animali
Scienza
Vetrine/Shopping
Veterinaria
Industria
Zoetis Launches Portela® (relfovetmab) in Canada and the European Union
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0
15/07/2026
Scienza
Veterinaria
Biotecnologia
Farmaceutica
Animali
Salute
Vetrine/Shopping
Industria
Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union
Fonte
Zoetis Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0